{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:06:33Z","timestamp":1761660393069,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["5380"],"award-info":[{"award-number":["5380"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1186\/s43141-021-00250-y","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T03:10:46Z","timestamp":1633835446000},"page":"150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy"],"prefix":"10.1016","volume":"19","author":[{"given":"Abdelfattah M.","family":"Attallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Omran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4111-0682","authenticated-orcid":false,"given":"Mohamed A.","family":"Abdelrazek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Hassany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"Saif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aza","family":"Farid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riham","family":"El Essawey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Abdel","family":"Ghaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Aabdelghany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Yosry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1186\/s43141-021-00250-y_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/jir.2016.0078","article-title":"Both hepatitis C virus-specific T cell responses and IL28B rs12979860 single-nucleotide polymorphism genotype influence antihepatitis C virus treatment outcome in patients with chronic hepatitis C","volume":"37","author":"Benito","year":"2017","journal-title":"J Interferon Cytokine Res"},{"issue":"8","key":"10.1186\/s43141-021-00250-y_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2013.109309","article-title":"Efficacy of sofosbuvir and ribavirin for treatment of hepatitis C genotype-1 in an inner city population: virus and host factors that predict relapse: a randomized controlled trial","volume":"310","author":"Osinusi","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1186\/s43141-021-00250-y_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S2055-6640(20)30491-X","article-title":"HCV cure for everyone or which challenges remain?","volume":"1","author":"Rockstroh","year":"2015","journal-title":"J Virus Erad"},{"issue":"20","key":"10.1186\/s43141-021-00250-y_bib4","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1186\/s43141-021-00250-y_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.2014.7734","article-title":"Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection","volume":"312","author":"Sulkowski","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1186\/s43141-021-00250-y_bib6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MCG.0b013e3182680221","article-title":"IL28B in the era of direct-acting antivirals for hepatitis C","volume":"47","author":"Muir","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"10.1186\/s43141-021-00250-y_bib7","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/apt.14628","article-title":"Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt","volume":"47","author":"El Kassas","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1186\/s43141-021-00250-y_bib8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s11096-020-01085-2","article-title":"Impact of IL28B gene polymorphism on efficacy and safety of direct acting antivirals in hepatitis C Egyptian patients","volume":"42","author":"Ebid","year":"2020","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"10.1186\/s43141-021-00250-y_bib9","first-page":"HC16","article-title":"Effect of zinc supplementation on viral response in patients with chronic hepatitis C and beta thalassemia major, a pilot study","volume":"8","author":"Abbasinazari","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10.1186\/s43141-021-00250-y_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mnfr.201100511","article-title":"Zinc and its role in age-related inflammation and immune dysfunction","volume":"56","author":"Wong","year":"2012","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"10.1186\/s43141-021-00250-y_bib11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2460\/ajvr.1977.38.06.863","article-title":"Effects on interferon of heavy metal excess and zinc deficiency","volume":"38","author":"Gainer","year":"1977","journal-title":"Am J Vet Res"},{"issue":"12","key":"10.1186\/s43141-021-00250-y_bib12","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"10.1186\/s43141-021-00250-y_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.5604\/01.3001.0012.0918","article-title":"Extracellular matrix proteins substantiate IL-28B T allele effect on histological outcome of chronic hepatitis C","volume":"17","author":"Attallah","year":"2018","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1186\/s43141-021-00250-y_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/clpt.2013.203","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-alpha-based regimens","volume":"95","author":"Muir","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1186\/s43141-021-00250-y_bib15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1186\/s43141-021-00250-y_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2217\/pme.14.60","article-title":"The birth and potential death of IL28B genotyping for hepatitis C therapy","volume":"12","author":"Wu","year":"2015","journal-title":"Per Med"},{"issue":"8","key":"10.1186\/s43141-021-00250-y_bib17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/MEG.0000000000000649","article-title":"Short article: faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study","volume":"28","author":"Zeuzem","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"10.1186\/s43141-021-00250-y_bib18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cmi.2016.09.017","article-title":"Role of assessing liver fibrosis in management of chronic hepatitis C virus infection","volume":"22","author":"Carmona","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1186\/s43141-021-00250-y_bib19","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1186\/s40064-016-3663-6","article-title":"IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study","volume":"5","author":"Mangia","year":"2016","journal-title":"SpringerPlus"},{"issue":"11","key":"10.1186\/s43141-021-00250-y_bib20","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1128\/JVI.00016-14","article-title":"Reduction of microRNA 122 expression in IFNL3 CT\/TT carriers and during progression of fibrosis in patients with chronic hepatitis C","volume":"88","author":"Estrabaud","year":"2014","journal-title":"J Virol"},{"issue":"6","key":"10.1186\/s43141-021-00250-y_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/cs0830695","article-title":"Relationship between hepatic lipid peroxidation and fibrogenesis in carbon tetrachloride-treated rats: effect of zinc administration","volume":"83","author":"Camps","year":"1992","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1186\/s43141-021-00250-y_bib22","first-page":"178","article-title":"Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C","volume":"51","author":"Matsumura","year":"2012","journal-title":"Journal of Clinical Biochemistry and Nutrition"},{"issue":"1","key":"10.1186\/s43141-021-00250-y_bib23","doi-asserted-by":"crossref","first-page":"15245","DOI":"10.1038\/ncomms15245","article-title":"Zinc is a potent and specific inhibitor of IFN-\u03bb3 signalling","volume":"8","author":"Read","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1186\/s43141-021-00250-y_bib24","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1038\/ncomms7422","article-title":"Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease","volume":"6","author":"Eslam","year":"2015","journal-title":"Nat Commun"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-021-00250-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43141-021-00250-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23006327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23006327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-021-00250-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:02:10Z","timestamp":1761660130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X23006327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1687157X23006327"],"URL":"https:\/\/doi.org\/10.1186\/s43141-021-00250-y","relation":{},"ISSN":["1687-157X"],"issn-type":[{"type":"print","value":"1687-157X"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s43141-021-00250-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Academy of Scientific Research and Technology. Published by Elsevier BV.","name":"copyright","label":"Copyright"}],"article-number":"150"}}